Contraceptive Drugs Market Size, Share & Industry Analysis, By Product (Oral (Combined Contraceptives and Progestin-only Pills), Injectable, and Patches), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels & NGOs, and Others), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 8.2% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Product

• Oral
  • Combined Contraceptives
  • Progestin-only Pills
• Injectable
• Patches

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channels
• Public Channels & NGOs
• Others

By Region

• North America (By Product, By Distribution Channel, and By Country)
  • U.S. (By Product)
  • Canada (By Product)
• Europe (By Product, By Distribution Channel, and By Country/Sub-region)
  • U.K. (By Product)
  • Germany (By Product)
  • France (By Product)
  • Italy (By Product)
  • Spain (By Product)
  • Scandinavia (By Product)
  • Rest of Europe (By Product)
• Asia Pacific (By Product, By Distribution Channel, and By Country/Sub-region)
  • Japan (By Product)
  • China (By Product)
  • India (By Product)
  • Australia (By Product)
  • Southeast Asia (By Product)
  • Rest of Asia Pacific (By Product)
• Latin America (By Product, By Distribution Channel, and By Country/Sub-region)
  • Brazil (By Product)
  • Mexico (By Product)
  • Rest of Latin America (By Product)
• Middle East & Africa (By Product, By Distribution Channel, and By Country/Sub-region)
  • GCC (By Product)
  • South Africa (By Product)
  • Rest of Middle East & Africa (By Product)